-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
January 01, 2023 - Medications most commonly used off label in the United States for adults with
AUDs
Drug Class Drug … National Survey on
Drug Use and Health, Detailed Tables 2019. … Drug
Alcohol Depend. 2006 Feb 1;81(2):149-55. doi:
10.1016/j.drugalcdep.2005.06.007. … Drug and alcohol abuse: a clinical guide to diagnosis and treatment.
6th ed. … Neurobiological basis of drug
reinforcement.
-
effectivehealthcare-admin.ahrq.gov/products/antidepressants-update/research
December 01, 2019 - White Paper
Jan 07, 2025
Enhancing Systematic Review Methods by Incorporating Unpublished Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
May 07, 2010 - List of angiotensin converting enzyme inhibitors (ACEIs), with the U.S.Food and Drug
Administration … X versus an
ARB + drug X (e.g., losartan + hydrochlorothiazide [HCTZ] versus enalapril
+ HCTZ) … • We will exclude comparisons of an ACEI + drug X versus an ARB + drug Y
(e.g., enalapril + manidipine … “ACE inhibitors” or unspecified
“ARBs” vs. unspecified “ACEIs”
- Include ACEI + drug X vs. … ARB + drug X (e.g., losartan + HCTZ vs. enalapril + HCTZ)
- Exclude ACEI + drug X vs.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
June 04, 2010 - Food and Drug Administration (FDA). … antipsychotic
drug. … All formulations of drug delivery (e.g., tablet, liquid, injectable) and
doses are eligible. … dose of the same antipsychotic drug. … National Library of Medicine’s TOXLINE® and MedEffectTM Canada Adverse
Drug Reaction Database.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Designed Delays Versus
Rigorous Pragmatic Trials: Lower Carat Gold Standards Can Produce Relevant Drug … Studying
Prescription Drug Use and Outcomes with Medicaid Claims Data: Strengths, Limitations,
and … Developing Indicators of Inpatient Adverse Drug
Events Through Non-Linear Analysis Using Administrative … Evaluation and Overview
of the National Electronic Injury Surveillance System- Cooperative Adverse Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
January 01, 2012 - similar drugs in the same class are read separately), and then topics in the same class of a
device, drug … Food and Drug
administration (FDA) for the agent in late 2012. … have been used for
ensuring intranasal delivery, including needle-less nostril syringes, a nasal drug … methods have been used, including needle-less syringes inserted
into alternating nostrils, a nasal drug … Food and Drug Administration (FDA); 2010
Dec 20. 86 p.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
August 06, 2018 - Reaction Reporting Systems"] or [mh Accidents] or
accident*:ti,ab or [mh "Drug Toxicity"] or [mh "Drug … Allergies" OR DE
"Drug Dependency" OR TX “drug effects” OR DE
"Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR accident*
OR “Drug Toxicity” OR “Drug Hypersensitivity … Allergies" OR DE
"Drug Dependency" OR TX “drug effects” OR
DE "Drug Sensitivity" OR TX harm* OR TX … Reaction Reporting Systems” OR Accidents OR
accident* OR “Drug Toxicity” OR “Drug
Hypersensitivity
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - recommends that selection of an
antipsychotic should be based on a patient’s previous responses to the drug … Study inclusion in the CER will not be limited by drug dosage.
4. … Food and
Drug Administration (FDA).
Comparators: Any commercially available FDA-approved SGA. … All methods of drug delivery (e.g., tablet, liquid, injection) will be eligible. … (neuroleptic adj2 (agent* or drug*)).tw.
28. or/25-27
29.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s3.pdf
October 01, 2007 - about the
occurrence and outcomes of conditions that were being targeted by therapies in the Merck
drug … Beyond pharmacoepide-
miology: the larger role of epidemiology in drug development. … Exposure-time-varying hazard function ratios in case-control
studies of drug effects. … Pharmacoepidemiol Drug Saf. 2006;15:81–92.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
January 01, 2015 - Twenty studies were drug trials (59%). … All eight pooled
analyses of patient-level RCT data were drug studies. … Corresponding and other authors in drug
trials were often industry employees. … Most drug trials were placebo-controlled RCTs. … Reporting issues were particularly
prominent in drug studies.
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
January 01, 2020 - used to identify adults with both a diagnosis of RA and at least one disease modifying anti-rheumatic drug … Register, other investigators reported that 18% of patients who initially met ACR criteria for RA were in drug-free … Trends in prescription drug expenditures by Medicaid enrollees. … A Blue Report on High Prescription Drug Use in Tennessee and its Consequences. Blue Series. … Postpartum Hypertensive Disorders of Pregnancy
Systematic Review
ARCHIVED
Jul 16, 2018
Drug
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - In
2001, teduglutide received orphan drug designation for treatment of SBS. … In August 2011,
NPS began submitting data for a new drug application to FDA for the same indication … Additional, less salient considerations included potential drug-drug
interactions, the possibility … The drug
is also expected to be widely accepted by patients. … Food and Drug Administration (FDA);
2009 Oct 2 [accessed 2011 Feb 14]. [2 p].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Food and Drug Administration (FDA) recently
placed a box warning on the entire class of biologic
DMARDs … Health Assessment Questionnaire;
CI = confidence interval; DMARD(s) = disease-modifying anti-rheumatic drug
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/does-use-of-generic-medications-for-seizures-result-in-poorer-control-more-er-visits-and-or-hospitalizations-than-the-use-of-brand-name-medications
November 01, 2017 - Appropriateness for EHC Program
Does your question include a health care drug, intervention, device … interest in drug related topics.
-
effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research
December 01, 2019 - Food and Drug Administration (FDA).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0316_03-12-2009.pdf
January 01, 2009 - It can also be used to adjust anti-hypertensive drug therapy and reduce clinic visits
with patients. … Use of anti-hypertensive drug therapy
iv. BP control
3. … Use of anti-hypertensive drug therapy
iv. BP control
4.
-
effectivehealthcare-admin.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
March 01, 2020 - Food and Drug Administration (FDA) issued a warning in January 2008 linking the use of bisphosphonates … For titles obtained from the search for AEs by drug of interest, titles will be accepted if they suggest … that the manuscript includes information on the relationship between the AE and the drug. … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.
-
effectivehealthcare-admin.ahrq.gov/products/multiple-sclerosis/research-protocol
December 01, 2019 - Food and Drug Administration; IV = intravenous; PRMS = primary progressive multiple sclerosis; RRMS = … What drug should I start with? … When should I switch a patient to a new drug and what should that drug be? … MS/Drug Holiday:
Database: Ovid MEDLINE
Search Strategy:
1 - exp multiple sclerosis/dt, th, im … /dt, im, th [Drug Therapy, Immunology, Therapy]
2 - exp Interferon-beta/
3 - interferon beta.mp.
4
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs.
c. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Food and Drug Administration [FDA] approved) and the specific clinical indication for
which they are … Designation Database
12
A database of drugs that have received
orphan drug status.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Is it a generic drug? If so, do not select, because these are “me-too” of existing drugs.
c. … Does this appear to be a different/off-label use of an available drug, biologic, or device? … Is this a different delivery mode for an existing drug or device? … Food and Drug Administration [FDA] approved) and the specific clinical indication for
which they are … Designation Database
12
A database of drugs that have received
orphan drug status.